(EL) Estee Lauder Companies - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5184391044

Skincare, Makeup, Fragrance, Haircare, Tools

Stock: Personal Care Products
Age 30.2y

MCap 41,459m
Avg Vol 2.98M (327M USD)

Beta 1.389
Volatility 42.87%

EPS (Earnings per Share)

EPS CAGR: -61.50%
EPS Trend: -58.1%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: -11.65%
Rev. Trend: -60.5%

Last SUE: 0.05
Qual. Beats: 0

Dividends

Dividend Yield	1.77%
Yield on Cost 5y	0.59%
Yield CAGR 5y	-10.58%
Payout Consistency	96.6%
Payout Ratio	83.3%

Risk via 5d forecast
Volatility	42.9%
Value at Risk 5%th	61.0%
Relative Tail Risk	-13.52%

Reward TTM
Sharpe Ratio	1.00
Alpha	33.63
CAGR/Max DD	-0.29

Character TTM
Hurst Exponent	0.462
Beta	1.389
Beta Downside	1.729

Drawdowns 3y
Max DD	81.40%
Mean DD	54.48%
Median DD	59.84%

Description: EL Estee Lauder Companies December 17, 2025

The Estée Lauder Companies (NYSE: EL) designs, manufactures, markets, and sells prestige skin-care, makeup, fragrance, and hair-care products worldwide, operating through a mix of department stores, specialty retailers, e-commerce platforms, and direct-to-consumer channels.

Its portfolio spans 25+ brands-including La Mer, Jo Malone London, Tom Ford, Clinique, M·A·C, The Ordinary, Aveda, and Too Faced-covering the full spectrum of personal-care categories from moisturizers and serums to perfumes and styling products.

Distribution is highly diversified: high-end department stores and perfumeries, duty-free outlets, upscale salons and spas, as well as growing online pure-player sites and the company’s own e-commerce portals.

Key recent metrics (FY 2023) show net sales of roughly $17.7 billion, a 9 % year-over-year increase driven largely by a 22 % rise in Asia-Pacific sales, and adjusted EPS of $6.80, reflecting strong margin expansion in the digital channel.

Sector-wide, the prestige beauty market is buoyed by rising consumer spending on premium personal-care, accelerated digital adoption, and a shift toward “clean” and “inclusive” product narratives; however, macro-level risks include inflation-driven discretionary cutbacks and currency volatility in emerging markets.

For a deeper, data-driven valuation framework, you may find ValueRay’s analyst tools worth a look.

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (-930.0m TTM) > 0 and > 6% of Revenue (6% = 866.5m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA -0.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 11.29% (prev 11.19%; Δ 0.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.08 (>3.0%) and CFO 1.60b > Net Income -930.0m (YES >=105%, WARN >=100%)

Net Debt (7.20b) to EBITDA (451.0m) ratio: 15.97 <= 3.0 (WARN <= 3.5)

Current Ratio 1.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (363.3m) change vs 12m ago 1.03% (target <= -2.0% for YES)

Gross Margin 74.19% (prev 72.29%; Δ 1.90pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 71.06% (prev 72.48%; Δ -1.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -0.96 (EBITDA TTM 451.0m / Interest Expense TTM 398.0m) >= 6 (WARN >= 3)

Altman Z'' 3.09

(A) 0.08 = (Total Current Assets 6.71b - Total Current Liabilities 5.08b) / Total Assets 19.33b

(B) 0.60 = Retained Earnings (Balance) 11.59b / Total Assets 19.33b

(D) 0.68 = Book Value of Equity 10.46b / Total Liabilities 15.44b

Total Rating: 3.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 25.56

1. Piotroski 2.50pt

2. FCF Yield 2.15%

3. FCF Margin 7.24%

4. Debt/Equity 2.42

5. Debt/Ebitda 15.97

6. ROIC - WACC (= -11.77)%

7. RoE -22.87%

8. Rev. Trend -60.55%

9. EPS Trend -58.14%

What is the price of EL shares?

As of January 20, 2026, the stock is trading at USD 115.05 with a total of 2,913,789 shares traded.
Over the past week, the price has changed by +1.80%, over one month by +6.53%, over three months by +12.64% and over the past year by +48.55%.

Is EL a buy, sell or hold?

Estee Lauder Companies has received a consensus analysts rating of 3.11. Therefor, it is recommend to hold EL.

Strong Buy: 2
Buy: 1
Hold: 23
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the EL price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	109	-5.3%
Analysts Target Price	109	-5.3%
ValueRay Target Price	113.7	-1.1%

EL Fundamental Data Overview January 19, 2026

P/E Forward = 57.8035
P/S = 2.87
P/B = 10.658
P/EG = 3.5688
Revenue TTM = 14.44b USD
EBIT TTM = -381.0m USD
EBITDA TTM = 451.0m USD
Long Term Debt = 7.32b USD (from longTermDebt, last quarter)
Short Term Debt = 418.0m USD (from shortTermDebt, last quarter)
Debt = 9.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.20b USD (from netDebt column, last quarter)
Enterprise Value = 48.66b USD (41.46b + Debt 9.42b - CCE 2.22b)
Interest Coverage Ratio = -0.96 (Ebit TTM -381.0m / Interest Expense TTM 398.0m)
EV/FCF = 46.57x (Enterprise Value 48.66b / FCF TTM 1.04b)
FCF Yield = 2.15% (FCF TTM 1.04b / Enterprise Value 48.66b)
FCF Margin = 7.24% (FCF TTM 1.04b / Revenue TTM 14.44b)
Net Margin = -6.44% (Net Income TTM -930.0m / Revenue TTM 14.44b)
Gross Margin = 74.19% ((Revenue TTM 14.44b - Cost of Revenue TTM 3.73b) / Revenue TTM)
Gross Margin QoQ = 73.37% (prev 71.97%)
Tobins Q-Ratio = 2.52 (Enterprise Value 48.66b / Total Assets 19.33b)
Interest Expense / Debt = 0.91% (Interest Expense 86.0m / Debt 9.42b)
Taxrate = 21.0% (US default 21%)
NOPAT = -301.0m (EBIT -381.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.32 (Total Current Assets 6.71b / Total Current Liabilities 5.08b)
Debt / Equity = 2.42 (Debt 9.42b / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = 15.97 (Net Debt 7.20b / EBITDA 451.0m)
Debt / FCF = 6.89 (Net Debt 7.20b / FCF TTM 1.04b)
Total Stockholder Equity = 4.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.58% (Net Income -930.0m / Total Assets 19.33b)
RoE = -22.87% (Net Income TTM -930.0m / Total Stockholder Equity 4.07b)
RoCE = -3.35% (EBIT -381.0m / Capital Employed (Equity 4.07b + L.T.Debt 7.32b))
RoIC = -2.65% (negative operating profit) (NOPAT -301.0m / Invested Capital 11.37b)
WACC = 9.12% (E(41.46b)/V(50.88b) * Re(11.03%) + D(9.42b)/V(50.88b) * Rd(0.91%) * (1-Tc(0.21)))
Discount Rate = 11.03% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.46%
[DCF Debug] Terminal Value 65.31% ; FCFF base≈1.16b ; Y1≈761.6m ; Y5≈347.5m
Fair Price DCF = N/A (negative equity: EV 5.69b - Net Debt 7.20b = -1.51b; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -58.14 | EPS CAGR: -61.50% | SUE: -4.0 | # QB: 0
Revenue Correlation: -60.55 | Revenue CAGR: -11.65% | SUE: 0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.74 | Chg30d=+0.004 | Revisions Net=+3 | Analysts=19
EPS current Year (2026-06-30): EPS=2.17 | Chg30d=+0.009 | Revisions Net=+7 | Growth EPS=+43.5% | Growth Revenue=+4.3%
EPS next Year (2027-06-30): EPS=2.94 | Chg30d=+0.008 | Revisions Net=+6 | Growth EPS=+35.6% | Growth Revenue=+3.9%

Additional Sources for EL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle